SK292003A3 - Pleuromutilin derivatives having antibacterial activity and pharmaceutical composition comprising the same - Google Patents

Pleuromutilin derivatives having antibacterial activity and pharmaceutical composition comprising the same Download PDF

Info

Publication number
SK292003A3
SK292003A3 SK29-2003A SK292003A SK292003A3 SK 292003 A3 SK292003 A3 SK 292003A3 SK 292003 A SK292003 A SK 292003A SK 292003 A3 SK292003 A3 SK 292003A3
Authority
SK
Slovakia
Prior art keywords
compound
acetyl
mutilin
group
present
Prior art date
Application number
SK29-2003A
Other languages
English (en)
Slovak (sk)
Inventor
Gerd Ascher
Heinz Berner
Original Assignee
Biochemie Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biochemie Gmbh filed Critical Biochemie Gmbh
Publication of SK292003A3 publication Critical patent/SK292003A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/53Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being saturated and containing rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/52Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/93Spiro compounds
    • C07C2603/95Spiro compounds containing "not free" spiro atoms
    • C07C2603/98Spiro compounds containing "not free" spiro atoms containing at least one ring with more than six ring members
    • C07C2603/99Spiro compounds containing "not free" spiro atoms containing at least one ring with more than six ring members containing eight-membered rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SK29-2003A 2000-07-11 2001-07-09 Pleuromutilin derivatives having antibacterial activity and pharmaceutical composition comprising the same SK292003A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0017031.6A GB0017031D0 (en) 2000-07-11 2000-07-11 Antimicrobials
PCT/EP2001/007875 WO2002004414A1 (fr) 2000-07-11 2001-07-09 Derives de pleuromutiline presentant une activite antibacterienne

Publications (1)

Publication Number Publication Date
SK292003A3 true SK292003A3 (en) 2003-07-01

Family

ID=9895454

Family Applications (1)

Application Number Title Priority Date Filing Date
SK29-2003A SK292003A3 (en) 2000-07-11 2001-07-09 Pleuromutilin derivatives having antibacterial activity and pharmaceutical composition comprising the same

Country Status (29)

Country Link
US (1) US6753445B2 (fr)
EP (1) EP1305282B1 (fr)
JP (2) JP4255282B2 (fr)
KR (1) KR100893426B1 (fr)
CN (1) CN1308301C (fr)
AR (1) AR029590A1 (fr)
AT (1) ATE408596T1 (fr)
AU (2) AU7638901A (fr)
BR (1) BRPI0112452B8 (fr)
CA (1) CA2412932C (fr)
CZ (1) CZ200342A3 (fr)
DE (1) DE60135848D1 (fr)
EC (1) ECSP024400A (fr)
ES (1) ES2313969T3 (fr)
GB (1) GB0017031D0 (fr)
HK (1) HK1052683B (fr)
HU (1) HU229510B1 (fr)
IL (2) IL153839A0 (fr)
MX (1) MXPA02012828A (fr)
NO (1) NO329091B1 (fr)
NZ (1) NZ523415A (fr)
PE (1) PE20020144A1 (fr)
PL (1) PL209305B1 (fr)
RU (1) RU2003103101A (fr)
SI (1) SI1305282T1 (fr)
SK (1) SK292003A3 (fr)
TW (1) TWI311552B (fr)
WO (1) WO2002004414A1 (fr)
ZA (1) ZA200300280B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0017031D0 (en) 2000-07-11 2000-08-30 Biochemie Gmbh Antimicrobials
GB0207495D0 (en) * 2002-03-28 2002-05-08 Biochemie Gmbh Organic compounds
GB0209262D0 (en) 2002-04-23 2002-06-05 Biochemie Gmbh Organic compounds
GB0513058D0 (en) * 2005-06-27 2005-08-03 Sandoz Ag Organic compounds
EP2298733B1 (fr) * 2005-06-27 2016-05-25 Nabriva Therapeutics AG Dérivés de la pleuromutiline contenant un groupe hydroxyamino- ou acyloxyaminocycloalkyle
GB0515995D0 (en) * 2005-08-03 2005-09-07 Sandoz Ag Organic compounds
EP1808431A1 (fr) * 2006-01-16 2007-07-18 Nabriva Therapeutics Forschungs GmbH Dérivés de mutiline et leur utilisation en tant que composé pharmaceutique
EP1972618A1 (fr) * 2007-03-20 2008-09-24 Nabriva Therapeutics AG Dérivés de pleuromutilin pour le traitement des maladies médiées par des microbes
WO2008143343A1 (fr) 2007-05-24 2008-11-27 Kyorin Pharmaceutical Co., Ltd. Dérivé de la mutiline ayant une structure d'acide carboxylique à noyau aromatique hétérocyclique en substituant à la position 14
EP2159220A1 (fr) * 2008-09-02 2010-03-03 Nabriva Therapeutics AG Composés organiques
CN101671367B (zh) * 2008-09-12 2012-09-05 中国科学院上海药物研究所 截短侧耳素磷酸酯类化合物、其药物组合物及其制备方法和用途
WO2010056855A1 (fr) * 2008-11-13 2010-05-20 Teva Pharmaceutical Industries Ltd. Préparation de rétapamuline par l'intermédiaire de son précurseur pleuromutiline-thiol
EP2399904A1 (fr) * 2010-05-26 2011-12-28 Nabriva Therapeutics AG Procédé de préparation de pleuromutilines
CN103204787B (zh) * 2012-01-17 2014-10-01 北京艾百诺科技有限公司 含有取代方酸的乙酸妙林酯及其应用
CN102924350B (zh) * 2012-10-31 2014-04-09 中国农业科学院兰州畜牧与兽药研究所 截短侧耳素衍生物及其制备方法和应用
TWI762573B (zh) 2017-02-10 2022-05-01 奧地利商納畢瓦治療有限責任公司 截短側耳素之純化
US11518740B2 (en) * 2021-04-24 2022-12-06 Shaanxi University Of Science And Technology Pleuromutilin (phenylthio)acetic acid ester with anti-drug resistant bacteria activity and a method of preparing the same
CN115850137B (zh) * 2022-11-12 2024-04-12 中国农业科学院兰州畜牧与兽药研究所 一种截短侧耳素衍生化合物及其制备方法与应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT301753B (de) * 1969-07-25 1972-09-25 Biochemie Gmbh Verfahren zur Herstellung neuer Pleuromutilin-Derivate
BE789629A (fr) * 1971-10-05 1973-04-03 Sandoz Sa Nouveaux derives de la pleuromutiline, leur preparation et leurapplication en therapeutique
FR2526019A1 (fr) * 1982-04-28 1983-11-04 Sandoz Sa Nouveaux derives de la pleuromutiline, leur preparation et leur utilisation comme medicaments
BE896512A (fr) * 1982-04-28 1983-10-20 Sandoz Ag Nouveaux derives de la pleuromutiline, leur preparation et leur utilisation comme medicaments
EP0153277B1 (fr) * 1984-02-17 1987-08-26 Sandoz Ag Dérivés de pleuromutiline, leur procédé de préparation et leur application
HU208115B (en) * 1989-10-03 1993-08-30 Biochemie Gmbh New process for producting pleuromutilin derivatives
JP3054875B2 (ja) * 1995-02-13 2000-06-19 株式会社小松製作所 プラズマトーチ
GB9614017D0 (en) * 1996-07-04 1996-09-04 Biochemie Gmbh Organic compounds
UY25225A1 (es) 1997-10-29 2000-12-29 Smithkline Beecham Plc Derivados de pleuromutilina utiles como agentes antimicrobianos
WO2000027790A1 (fr) 1998-11-11 2000-05-18 Smithkline Beecham P.L.C. Composes a base de mutiline
GB0017031D0 (en) 2000-07-11 2000-08-30 Biochemie Gmbh Antimicrobials

Also Published As

Publication number Publication date
NO20030100L (no) 2003-01-09
HUP0301478A2 (hu) 2003-09-29
JP5173763B2 (ja) 2013-04-03
NZ523415A (en) 2004-10-29
NO329091B1 (no) 2010-08-23
CZ200342A3 (cs) 2003-04-16
RU2003103101A (ru) 2004-07-27
IL153839A0 (en) 2003-07-31
HUP0301478A3 (en) 2006-02-28
EP1305282A1 (fr) 2003-05-02
BR0112452A (pt) 2003-07-22
JP4255282B2 (ja) 2009-04-15
CN1441778A (zh) 2003-09-10
JP2009108088A (ja) 2009-05-21
US20030162831A1 (en) 2003-08-28
SI1305282T1 (sl) 2009-02-28
HU229510B1 (en) 2014-01-28
MXPA02012828A (es) 2003-09-05
PE20020144A1 (es) 2002-03-08
WO2002004414A1 (fr) 2002-01-17
IL153839A (en) 2012-03-29
CN1308301C (zh) 2007-04-04
GB0017031D0 (en) 2000-08-30
TWI311552B (en) 2009-07-01
EP1305282B1 (fr) 2008-09-17
ATE408596T1 (de) 2008-10-15
KR20030066581A (ko) 2003-08-09
HK1052683A1 (en) 2003-09-26
BRPI0112452B8 (pt) 2021-05-25
AU2001276389B2 (en) 2005-03-03
HK1052683B (zh) 2009-05-22
JP2004502755A (ja) 2004-01-29
AR029590A1 (es) 2003-07-02
CA2412932A1 (fr) 2002-01-17
BRPI0112452B1 (pt) 2015-06-09
PL358674A1 (en) 2004-08-09
KR100893426B1 (ko) 2009-04-17
CA2412932C (fr) 2011-01-04
NO20030100D0 (no) 2003-01-09
US6753445B2 (en) 2004-06-22
ECSP024400A (es) 2003-02-06
PL209305B1 (pl) 2011-08-31
ZA200300280B (en) 2004-04-08
AU7638901A (en) 2002-01-21
ES2313969T3 (es) 2009-03-16
DE60135848D1 (de) 2008-10-30

Similar Documents

Publication Publication Date Title
JP5173763B2 (ja) 抗細菌活性を有するプレウロムチリン誘導体
ES2357443T3 (es) Derivados mutilina y su uso como antimicrobianos.
AU2001276389A1 (en) Pleuromutilin derivatives having antibacterial activity
US7790767B2 (en) Pleuromutilin derivatives containing a hydroxyamino- or acyloxyaminocycloalkyl group
TWI423796B (zh) 有機化合物
DE60317208T2 (de) Pleuromutilinderivate als antimikrobielle mittel
CA2734392C (fr) Derives de pleuromutiline ayant une stabilite metabolique amelioree
BRPI0707117B1 (pt) Derivados de mutilina, seu uso, e composição farmacêutica
BRPI0113837B1 (pt) compostos mutilinas com atividade antimicrobiana e composição farmacêutica que os compreende
JP6125425B2 (ja) 微生物によって媒介される疾患の治療に用いるプレウロムチリン誘導体

Legal Events

Date Code Title Description
FB9A Suspension of patent application procedure